Free Design Audit Available - Click Here for Details

FDA clears Getinge’s cardiovascular surgery offering, company launches new table, light in U.S.

Getinge this week announced a major FDA clearance and the beginning of a U.S. launch of multiple surgical tools.

The Gothenburg, Sweden-based company won 510(k) clearance for its Vasoview Hemopro 3. This adds to the company’s portfolio of endoscopic vessel harvesting (EVH) solutions.

Getinge said it designed the system with customer centricity top-of-mind. It hopes to offer enhanced procedural efficiency with the upcoming launch of this product, according to a news release. The company anticipates a U.S. launch in the third quarter of 2024. Submissions for approval in other key markets remains in progress.

Advanced features include enhanced smoke evacuation, regulated energy control, ergonomic game controller-style handle and an integrated cable.

Sign up for Blog Updates